1 |
Lack of personalization details (e.g. incorporation of genetic and acquired risk factors) |
2 |
Limited availability of experimental data used to validate computational models (e.g. limited access to atrial tissues other than atrial appendage and to patient cohorts without an indication for cardiac surgery) |
3 |
Limited pre-procedural availability of patient-specific electrophysiological information |
4 |
Inability to image patient-specific fibre orientations |
5 |
Limited spatial resolution of traditional MRI makes resolving the complex fibrosis patterns in the thin atrial walls challenging |
6 |
Intra-individual heterogeneities are not fully characterized |
7 |
Lack of cellular details in organ-level models that may be required to simulate realistic AAD effects due to high computational cost |
8 |
Issues regarding simulation of intervening gaps, PV reconnection, focal ectopic firing and progression of the underlying substrates due to continued atrial remodelling remain unresolved |
9 |
Complex integration with existing workflows and systems (e.g. requirement for LGE-MRI and its time-consuming segmentation, integration with electro-anatomical mapping systems) |
10 |
‘Black box’ characteristic of deep-learning based machine learning models |